These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15538567)

  • 41. Genome-wide determination of DNA methylation by Hpa II tiny fragment enrichment by ligation-mediated PCR (HELP) for the study of acute leukemias.
    Figueroa ME; Melnick A; Greally JM
    Methods Mol Biol; 2009; 538():395-407. PubMed ID: 19277580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylation status of the major breakpoint cluster region in Philadelphia chromosome negative leukemias.
    Litz CE; McClure JS; Coad JE; Goldfarb AN; Brunning RD
    Leukemia; 1992 Jan; 6(1):35-41. PubMed ID: 1346543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The expression and clinical significance of miR-203 in pediatric acute leukemia].
    Wang N; Pan J; Cao L; Lu J; Xiao PF; Zhao WL; Hu SY; Chai YH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):777-81. PubMed ID: 24103876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hypermethylation of the human calcitonin gene as a molecular marker in acute lymphoid leukemia].
    Marinich DV; Uss AL; Smirnova LA; Vorob'ev IA; Holmes J; Sulimova GE; Shevchuk TV; Bur'ianov IaI
    Vopr Med Khim; 2001; 47(5):537-46. PubMed ID: 11766265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The significance of DNA-binding inhibitor 4 promoter methylation status in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Dou LP
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):576-8. PubMed ID: 17074115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolated asymptomatic severe neutropenia as the presentation of myeloid/natural killer cell acute leukemia.
    Rubio-Batllés M; de La Mata AC; Romero Macias JR; Vitaller AR
    Haematologica; 2000 Mar; 85(3):322-4. PubMed ID: 10702827
    [No Abstract]   [Full Text] [Related]  

  • 47. MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.
    de Leeuw DC; van den Ancker W; Denkers F; de Menezes RX; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA; Smit L
    Clin Cancer Res; 2013 Apr; 19(8):2187-96. PubMed ID: 23444217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathobiology and clinical significance of molecular genetic findings in childhood tumors.
    Rubnitz JE; Downing JR; Crist WM
    Adv Pediatr; 1998; 45():315-36. PubMed ID: 9742307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic analysis of changes in sizes of telomeres and anti-oncogenes p53 and Rb in children with pre-B acute lymphoblastic leukemia].
    Klots IN; Indzhiia LV; Chepnian ER; Lapin BA
    Biull Eksp Biol Med; 1999 Apr; 127(4):439-41. PubMed ID: 10367131
    [No Abstract]   [Full Text] [Related]  

  • 50. Near-haploidy in myeloid antigen positive childhood acute lymphoblastic leukemia.
    Mukherjee S; Das Gupta A; Khodaiji S; Agarwal MB
    Am J Hematol; 2001 Aug; 67(4):276-7. PubMed ID: 11443648
    [No Abstract]   [Full Text] [Related]  

  • 51. The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Barrios M; Andreu EJ; Prosper F; Heiniger A; Torres A
    Leukemia; 2004 Feb; 18(2):362-5. PubMed ID: 14628074
    [No Abstract]   [Full Text] [Related]  

  • 52. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
    Roman-Gomez J; Jimenez-Velasco A; Barrios M; Prosper F; Heiniger A; Torres A; Agirre X
    Leuk Lymphoma; 2007 Jul; 48(7):1269-82. PubMed ID: 17613754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of acridine orange to DNA in situ of cells from patients with acute leukemia.
    Walle AJ; Wong GY
    Cancer Res; 1989 Jul; 49(13):3692-5. PubMed ID: 2731183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylation, aging, and pediatric acute lymphocytic leukemia.
    Garcia-Manero G
    Leukemia; 2003 Nov; 17(11):2063-4. PubMed ID: 12931218
    [No Abstract]   [Full Text] [Related]  

  • 58. DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL.
    Kraszewska MD; Dawidowska M; Larmonie NS; Kosmalska M; Sędek Ł; Szczepaniak M; Grzeszczak W; Langerak AW; Szczepański T; Witt M;
    Leukemia; 2012 Feb; 26(2):367-71. PubMed ID: 21836607
    [No Abstract]   [Full Text] [Related]  

  • 59. [LRP15 gene promoter region methylation and its expression in acute leukemia].
    Zhao Y; Dou LP; Wang QS; Lu XC; Lou FD; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):39-41. PubMed ID: 17490517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
    Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
    Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.